The 20 Best Acute Lymphoblastic Leukemia (ALL) Doctors in Utah, US

Dr. Pulsipher is currently the Division Chief of the Pediatric Hematology at Intermountain Primary Children's Hospital and Oncology, Director of the Children's and Adolescent Cancer Initiative at Huntsman Cancer Institute and a Presidential Chair in Pediatric Oncology and Hematology at the University of Utah.  Dr. Pulsipher is an internationally recognized expert in Bone Marrow Transplantation and Cellular Therapy, having directed the world's largest pediatric transplant research group for more than a decade (Pediatric Transplantation and Cellular Therapy Consortium).  He has run more than 20 multicenter trials in the field and is considered and expert in broad areas of transplantation and cellular therapy.  Areas of focus have included development of reduced toxicity approaches to transplantation of both malignant and non-malignant disorders with a focus on minimizing short and long-term effects of transplant.  For non-malignant disorders he has run national protocols that have improved safety for patients with immunodeficiencies, HLH, and bone marrow failure. For cancer, he has developed techniques allowing identification of patients who can avoid radiation-based treatments for leukemia.  This has included a novel approach to safer transplantation of patients using half-matched family donors (haploidentical donors) using a novel form of bone marrow graft engineering called alpha-beta T-cell depletion.  His desire to develop safer approaches has become a major focus as he has led major studies in the field of chimeric antigen receptor T-cells (CAR T-cells), a safer approach to cancer cure.  Dr. Pulsipher's work in cell therapy helped lead to the FDA approval of the first CART cell treatment, tisagenlecleucel, and he continues to run trials in CAR T, NK, and Viral Specific T-cell therapies. He has open protocols aimed at improving outcomes and his lab efforts are focused on making CAR T-cells that last longer and avoid overcome resistance by cancer cells. Dr. Pulsipher's interests have included ensuring that the families of those undergoing transplantation and cell therapy are psychologically well throughout the process.  To help with this, he has run several large trials assessing the safety and Quality of Life of pediatric bone marrow donors and is he currently running a large national trial looking at the psychological well-being of donor and recipient families as they go through the transplant process.For questions regarding Dr. Pulsipher's adult practice at the Huntsman Cancer Institute, or for questions about any of our clinical programs and for assistance identifying the right Hematology specialist for you or your family member, please contact our Clinical Care Specialist/New Patient Coordinator at (801) 587-4652. For questions regarding Dr. Pulsipher's pediatric practice and the Blood and Marrow Transplant Program at Primary Children's Medical Center, please call (801) 662-4830. Dr. Pulsipher is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Graft Versus Host Disease (GvHD), Leukemia, Severe Combined Immunodeficiency (SCID), and Bone Marrow Transplant.

Elizabeth Raetz is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Raetz is rated as an Elite provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Adult T-Cell Leukemia, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Raetz is currently accepting new patients.

Dr. McNeer is a Professor of Clinical Pediatrics at the University of Utah School of Medicine in the Division of Pediatric Hematology/Oncology and is the Medical Director for Pediatric Hematology/Oncology at Primary Children's Hospital. She is a member of the Leukemia and Lymphoma team at the University of Utah and Primary Children's Hospital.After receiving her medical degree from New York University School of Medicine, Dr. McNeer completed her residency at Children's Memorial Hospital (now Lurie Children's Hospital), which is affiliated with Northwestern University Feinberg School of Medicine. She then completed her fellowship in Pediatric Hematology/Oncology/Stem Cell Transplant at Children's Memorial Hospital, and during her fellowship earned a master's degree in clinical investigation at Northwestern University Feinberg School of Medicine.Dr. McNeer is board-certified in Pediatrics and Pediatric Hematology and Oncology. She has authored over 25 peer-reviewed journal articles and 4 book chapters. Dr. McNeer has been an invited speaker at many national and international conferences and symposiums. She is a member of the American Society of Clinical Oncology, American Society of Hematology, as well as the American Society of Pediatric Hematology/Oncology and the Children's Oncology Group.Dr. McNeer's clinical expertise is in the treatment of children, adolescents, and young adults with hematologic malignancies such as leukemia and lymphoma, in particular those with high-risk and relapsed/refractory acute lymphoblastic leukemia. She has a leadership role within the Children's Oncology Group Acute Lymphoblastic Leukemia committee, and partners with colleagues in adult oncology to collaborate in developing treatment protocols and clinical trials for young adults with leukemia. Her research focus is on the design and implementation of clinical trials for patients with hematologic malignancies.Dr. McNeer is invested in improving overall treatment outcomes for children, adolescents, and young adults, while tailoring therapy and supportive care to individual patients in order to minimize toxicity and optimize quality of life. Dr. Mcneer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Febrile Neutropenia, Infantile Neutropenia, and Bone Marrow Aspiration.

acute leukemias, lymphomas and blood and marrow stem cell transplant. Dr. Hoda is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Lymphoblastic Leukemia (ALL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Acute Leukemia and Lymphoma and blood and marrow/Stem cell transplant.Professional interests: Adolescent and Young Adults, Acute Lymphoblastic Leukemia. Personal interests: Skiing, biking, music. Dr. Asch is rated as an Advanced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Michael Boyer is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Boyer is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Hepatic Venoocclusive Disease with Immunodeficiency, Childhood Acute Myeloid Leukemia, and Bone Marrow Transplant.

Luke Maese is a Hematologist and an Oncologist in Salt Lake City, Utah. Dr. Maese is rated as a Distinguished provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rhabdomyosarcoma, and Adult Soft Tissue Sarcoma. Dr. Maese is currently accepting new patients.

Gabriela Motyckova is a Hematologist Oncology provider in Logan, Utah. Dr. Motyckova has been practicing medicine for over 21 years and is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Motyckova is currently accepting new patients.

Dr. Mangum received his medical degree from the Albert Einstein College of Medicine (affiliated with Yeshiva University). He then completed his Pediatric residency at Primary Children´s Hospital (affiliated with the University of Utah), which was followed by a pediatric Hematology Oncology Fellowship at St Jude Children's Research Hospital (affiliated with the University of Tennessee). Afterwards, he completed an additional two year Physician Scientist Training Program fellowship at St. Jude Children's Research Hospital while still also continuing to care for patients. Following this, Dr. Mangum joined the faculty of Nemours Children's Hospital in Delaware where he practiced for three years in pediatric hematology oncology. Dr. Mangum then joined the University of Utah in the Division of Pediatric Hematology Oncology at Primary Children's Hospital. Dr. Mangum's research interests have focused primarily on Acute Lymphoblastic Leukemia, with his clinical interests focused on patients with Leukemias, Lymphomas, and histiocytic disorders of all kinds. However, he is comfortable with caring for any patient across the entire pediatric hematology oncology spectrum. Dr. Mangum is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Leukemia, Rosai-Dorfman Disease, and Immune Thrombocytopenic Purpura (ITP).

Dr. Pyper is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Hematology team at the University of Utah and Primary Children's Hospital. He received his medical degree from Northwestern University Feinberg School of Medicine.Dr. Pyper completed his residency at the University of Vermont College of Medicine, University of Vermont Children's Hospital (Pediatrics). He completed his fellowship in Pediatric Hematology, Oncology and Bone Marrow Transplantation at the University of Minnesota Medical School, University of Minnesota Masonic Children's Hospital.Dr. Pyper is board-certified in Pediatrics and Pediatric Hematology and Oncology. He is a member of many professional societies, including The American Society of Pediatric Hematology/Oncology, The American Society for Hematology and the American Society for Transplantation and Cellular Therapy. He has many years teaching experience and has previously been awarded teacher of the year by the associated pediatric residency program. He also takes great interest in patient and family education to make sure that patients and families understand their medical issues in an age-appropriate way so that they are able to participate in decision-making and advocate well for themselves and their loved ones.Dr. Pyper's clinical interests include the treatment of pediatric disorders including non-malignant hematology, disorders of hemostasis and thrombosis, sickle cell disease, red cell membrane defects and hemoglobinopathies as well as bone marrow failure syndromes.His primary research interests include congenital and acquired risk factors for abnormal bleeding and clotting in pediatric patients as well as improving access to needed health care resources for high-risk pediatric patients affected by hematologic diseases. Dr. Pyper is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hereditary Spherocytosis, Hemolytic Anemia, Acute Lymphoblastic Leukemia (ALL), and Congenital Hemolytic Anemia.

Dr. Michelle Heather Gilbert is a Medical/Hematology Oncologist practicing in St. George with over 23 years of diverse experience. Dr. Heather Gilbert has been with Intermountain Cancer Center in St. George, Medical Oncology since January 2012. She recieved her Doctor of Medicine from the University of Utah Medical Center in 2001. When she is not working you can usually find her riding trails from all over. She is an enthusiastic mountain biker, trail hiker, and white-water river rafter. She has coached the Dixie High School mountain biking team for 12 years. She loves to travel with her husband, has two children, and the most adorable grandson in the whole history of the world. Dr. Gilbert is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Inflammatory Breast Cancer, Paget Disease of the Breast, Philadelphia-Negative Chronic Myeloid Leukemia, and Bone Marrow Aspiration.

I enjoy hiking, biking, backpacking, rock climbing, and spending time with my kids. Dr. Konopa is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Large-Cell Immunoblastic Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Dr. Dolan received his medical degree from the University of Washington and completed his Pediatric residency at Seattle Children´s Hospital.  He went on to pursue his Pediatric Hematology and Oncology Fellowship and advanced fellowship in cellular/immunotherapy and bone marrow transplant at the Children's Hospital of Philadelphia. He joined the faculty of the University of Utah in 2021 as an Assistant Professor of Pediatrics in the Division of Pediatric Hematology and Oncology.Dr. Dolan's clinical interests include the treatment of pediatric disorders requiring bone marrow transplant.  He has an emphasis on high-risk hematologic malignancies and cellular therapy designed to reduce toxicity in patients with relapsed and refractory disease.His primary research focuses on outcomes of children treated with cellular/immunotherapy products. He also has an interest in understanding the emotional and spiritual challenges that arise as part of the journey for patients and families diagnosed with cancer. Dr. Dolan is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hereditary Neuroblastoma, Neuroblastoma, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP).

Dr. Thomsen received his medical degree from the University Of Virginia School Of Medicine.  He completed a residency in general pediatrics at Wake Forest Baptist Medical Center where he also served as chief resident and practiced as a pediatric hospitalist.  He completed his clinical fellowship in pediatric hematology and oncology at the University of Utah.  He is currently an Assistant Professor in the Pediatric Hematology and Oncology Division at the University of Utah.Dr. Thomsen's clinical interests include care of children with childhood leukemia, lymphoma and various other cancers.  Dr. Thomsen's research focuses on improving care of children with childhood cancer by applying quality improvement principles to everyday care.  He is passionate about medical education and improving hematology-oncology education in pediatric residency programs and has a keen interest in improving access to pediatric hematology-oncology services throughout the intermountain west. Dr. Thomsen is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Glioma, Hereditary Neuroblastoma, and Neuroblastoma.

Dr. Fraley received her medical degree from the University of New Mexico School of Medicine, followed by a Pediatrics residency at Oregon Health & Science University. She then completed a Pediatric Hematology, Oncology, and Bone Marrow Transplant fellowship at Children's Hospital Colorado where she received additional training in clinical research through the Masters of Clinical Science program at the University of Colorado Anschutz Medical Campus. Dr. Fraley was an Instructor of Pediatrics for an additional year at Children's Hospital Colorado, where she continued to care for patients while also developing a program of research studying neurocognitive outcomes in children with cancer and blood disorders.Dr. Fraley is currently an Assistant Professor of Pediatrics at the University of Utah and is in the Division of Pediatric Hematology Oncology. Clinically, she cares for patients with leukemia and lymphoma as well as long term survivors of all cancers. Dr. Fraley's program of research examines neurocognitive dysfunction (i.e., difficulties with thinking, learning, and remembering) in childhood cancer survivors, including risk factors for dysfunction, the consequences of dysfunction, and interventions to prevent decline. Dr. Miller is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Acute Lymphoblastic Leukemia (ALL) and Immune Thrombocytopenic Purpura (ITP).

Bryan Huber is a Hematologist in Salt Lake City, Utah. Dr. Huber has been practicing medicine for over 13 years and is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), Diffuse Large B-Cell Lymphoma (DLBCL), Large-Cell Immunoblastic Lymphoma, and Bone Marrow Aspiration. Dr. Huber is currently accepting new patients.

Dr. Zachary Reese, MD is a hematologist/medical oncologist currently practicing with lntermountain Health in St. George Utah. He attended medical school at the University of Rochester School of Medicine and Dentistry in Rochester, NY, followed by internal medicine residency at the University of Colorado in Denver, CO. He then completed Hematology/Medical Oncology fellowship at the Huntsman Cancer Hospital at the University of Utah. He joined lntermountain in 2015 treating patients with all types of malignancies but with an emphasis on breast cancer. He has been providing teleoncology services to patients in rural communities since 2015 and has been serving as the lntermountain Teleoncology Medical Director since 2019. Dr. Reese is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Paget Disease of the Breast, Inflammatory Breast Cancer, Angiosarcoma, Bone Marrow Aspiration, and Endoscopy.

Richard Lemons, MD, PhD, is a professor in the Department of Pediatrics at the University of Utah School of Medicine, medical director and chief of pediatric hematology/oncology at Primary Children's Medical Center and the University of Utah, and a Huntsman Cancer Institute investigator. He is involved in various clinical trials for pediatric malignancies and pediatric hematologic disorders.Lemons earned a medical degree from George Washington University School of Medicine, Washington, DC; and performed an internship and residency at Johns Hopkins Hospital, Baltimore. Lemons was a staff member at St. Jude Children's Research Hospital prior to joining the University of Utah Department of Pediatrics. He is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Lemons is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are Hemophilia B, Infantile Neutropenia, Blood Clots, and Febrile Neutropenia.

Scott Johnson is a Radiologist in Salt Lake City, Utah. Dr. Johnson has been practicing medicine for over 18 years and is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). His top areas of expertise are CAPOS Syndrome, Hydrocephalus, Relapsing Multiple Sclerosis (RMS), and Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease. Dr. Johnson is currently accepting new patients.

Dr. Casey Mehrhoff received her Master of Science in Biomedical Sciences and medical degree from Kansas City University of Medicine, completed her Pediatric Residency at Loyola University Medical Center in Chicago, and her Pediatric Hematology/Oncology Fellowship at Ann & Robert H. Lurie Children's Hospital of Chicago. She is currently an Assistant Professor of Pediatrics at the University of Utah within the Division of Pediatric Hematology/Oncology at Primary Children's Hospital. Her clinical focus is on pediatric patients with solid tumor malignancies, with a specific focus on patients diagnosed with rare tumors and patients with cancer predisposition syndromes. She is the co-director and co-founder of the Pediatric Multidisciplinary Thyroid Team and is the co-director and founder of the Pediatric Multidisciplinary Melanoma program and is involved with these specialties on a national level. She is a provider in the high risk genetics cancer predisposition clinic at Huntsman Cancer Institute where she provides care and cancer screening for patients with certain cancer predisposition syndromes, such as Li Fraumeni Syndrome, DICER1, and Familial Adenomatous Polyposis, to name a few. Her research interest is in translational research and clinical trials. Dr. Mehrhoff is rated as an Experienced provider by MediFind in the treatment of Acute Lymphoblastic Leukemia (ALL). Her top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Acute Lymphoblastic Leukemia (ALL), and Immune Thrombocytopenic Purpura (ITP).